1-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Allele Carriers With Stroke or TIA
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial
Neurology 2024 Feb 13;102(3)e207809, X Meng, A Wang, X Tian, C Johnston, H Li, PM Bath, Q Xu, Y Zhang, X Xie, J Jing, J Lin, Y Wang, X Zhao, Z Li, Y Jiang, L Liu, Y WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.